GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Marsh & McLennan Companies Inc (NYSE:MMC) » Definitions » PE Ratio without NRI

Marsh & McLennan (Marsh & McLennan) PE Ratio without NRI

: 25.26 (As of Today)
View and export this data going back to 1969. Start your Free Trial

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2024-04-16), Marsh & McLennan's share price is $197.44. Marsh & McLennan's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $7.82. Therefore, Marsh & McLennan's PE Ratio without NRI for today is 25.26.

During the past 13 years, Marsh & McLennan's highest PE Ratio without NRI was 30.90. The lowest was 16.64. And the median was 21.97.

Marsh & McLennan's EPS without NRI for the three months ended in Dec. 2023 was $1.68. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $7.82.

As of today (2024-04-16), Marsh & McLennan's share price is $197.44. Marsh & McLennan's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $7.53. Therefore, Marsh & McLennan's PE Ratio for today is 26.22.

Good Sign:

Marsh & McLennan Companies Inc stock PE Ratio (=26.2) is close to 1-year low of 25.34

During the past years, Marsh & McLennan's highest PE Ratio was 38.20. The lowest was 16.67. And the median was 25.56.

Marsh & McLennan's EPS (Diluted) for the three months ended in Dec. 2023 was $1.52. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $7.53.

Marsh & McLennan's EPS (Basic) for the three months ended in Dec. 2023 was $1.53. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $7.60.


Marsh & McLennan PE Ratio without NRI Historical Data

The historical data trend for Marsh & McLennan's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marsh & McLennan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio without NRI
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.42 29.46 28.78 27.54 23.71

Marsh & McLennan Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PE Ratio without NRI Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.54 24.05 26.06 25.02 23.71

Competitive Comparison

For the Insurance Brokers subindustry, Marsh & McLennan's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marsh & McLennan PE Ratio without NRI Distribution

For the Insurance industry and Financial Services sector, Marsh & McLennan's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Marsh & McLennan's PE Ratio without NRI falls into.



Marsh & McLennan PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Marsh & McLennan's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=197.44/7.815
=25.26

Marsh & McLennan's Share Price of today is $197.44.
Marsh & McLennan's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.82.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Marsh & McLennan  (NYSE:MMC) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Marsh & McLennan PE Ratio without NRI Related Terms

Thank you for viewing the detailed overview of Marsh & McLennan's PE Ratio without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Marsh & McLennan (Marsh & McLennan) Business Description

Address
1166 Avenue of the Americas, New York, NY, USA, 10036-2774
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the U.S.
Executives
Oscar Fanjul director C/O OMEGA CAPITAL, S.L., PASEO DE LA CASTELLANA, 28, MADRID U3 28046
John Jude Jones officer: Chief Marketing Officer 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Dean Michael Klisura officer: President & CEO, Guy Carpenter 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Steven A Mills director IBM CORPORATION, 294 ROUTE 100, SOMERS NY 10589
Mark C Mcgivney officer: Chief Financial Officer
Judith Hartmann director 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Ray G Young director 77 WEST WACKER DR., SUITE 4600, CHICAGO IL 60601
Stacy Mills officer: Vice President and Controller C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENENUE OF THE AMERICAS, NEW YORK NY 11102
Paul Beswick officer: SVP, Chief Information Officer 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Martin South officer: President & CEO, Marsh 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Martine Ferland officer: President and CEO, Mercer C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Katherine Brennan officer: SVP and General Counsel 1166 AVENUE OF THE AMERICAS, 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Daniel S Glaser officer: Chairman & CEO, Marsh C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Hafize Gaye Erkan director 727 FIFTH AVENUE, NEW YORK NY 10022
Marc D Oken director C/O FALFURRIAS CAPITAL PARTNERS, 100 N. TRYON STREET, SUITE 5120, CHARLOTTE NC 28202